drugset / Trial / NCT01748344

Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis

NCT01748344

Phase 2 Completed 58 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to investigate if ONO-4053 relieves symptoms of allergic rhinitis in seasonal allergic rhinitis subjects exposed to pollen under controlled conditions.

Timeline

Start
2012-11
Primary completion
2014-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetirizine Other / unclassified 10 mg Oral
Subject ONO-4053 Unknown Oral